Cerebrospinal fluid and plasma biomarkers in Alzheimer disease

Kaj Blennow(University of Gothenburg), Harald Hampel(Trinity College Dublin), Michael W. Weiner(University of California, San Francisco), Henrik Zetterberg(University of Gothenburg)

Nature Reviews Neurology

February 16, 2010

10.1038/nrneurol.2010.4

Cited by 1,862

Abstract

Related Papers

Aβ Oligomers – a decade of discovery

Dominic M. Walsh, Dennis J. Selkoe|Journal of Neurochemistry|2007|1.9k

Amyloid β-peptide is produced by cultured cells during normal metabolism

Christian Haass, Michael G. Schlossmacher, Albert Y. Hung et al.|Nature|1992|1.9k

Cholinesterase inhibitors for Alzheimer's disease

Jacqueline Birks|Cochrane Database of Systematic Reviews|2006|1.9k

Tangles and plaques in nondemented aging and ?preclinical? Alzheimer's disease

Joseph L. Price, John C. Morris|Annals of Neurology|1999|1.7k

Association of Low Plasma Aβ42/Aβ40 Ratios With Increased Imminent Risk for Mild Cognitive Impairment and Alzheimer Disease

Neill R. Graff‐Radford, Julia E. Crook, John A. Lucas et al.|Archives of Neurology|2007|442